Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians

被引:11
作者
Andreassen, Mikkel [1 ]
Nielsen, Kaspar [2 ]
Raymond, Ilan [3 ]
Kristensen, Lars Ostergaard
Faber, Jens
机构
[1] Univ Copenhagen, Dept Endocrinol, Herlev Hosp, Lab Endocrinol 5404, DK-2730 Herlev, Denmark
[2] Aalborg Hosp, Reg Ctr Blood Transfus & Clin Immunol, Aalborg, Denmark
[3] Univ Copenhagen, Dept Cariol & Endodontol, Frederiksberg Hosp, DK-1168 Copenhagen, Denmark
关键词
Growth hormone; Insulin-like growth factor 1; reference ranges; assay validation; Enzyme-Linked Immunosorbent Assay; BINDING PROTEIN-3 IGFBP-3; FREE IGF-I; SERUM; ASSAYS; SEX; AGE; POPULATION; VALUES; WOMEN; MEN;
D O I
10.3109/00365510903165477
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background and Objective: Measurements of Insulin-Like Growth Factor-I (IGF-I) play a pivotal role in the evaluation of the growth hormone-IGF-I axis. Due to assay variation IGF-I reference ranges are assay specific. We provide serum IGF-I reference ranges for adult men and women obtained by a commercially available assay. Method: IGF-I was measured by an enzyme-linked immunosorbent assay (R&D Systems). Assay precision was evaluated in low, medium and high IGF-I pools and in single samples from outpatients. The reference ranges were obtained in 724 healthy Caucasians, mean age 48 years (range 19-91). Results: IGF-I was measured higher in serum compared to plasma samples (p < 0.001, R-2 = 0.96). To convert EDTA plasma values to serum values a factor of 1.22 was calculated. The intraassay coefficients of variation (CV) for the low: 56.4 +/- 2.7 ng/mL, medium: 179.7 +/- 5.9 ng/mL and high pool: 445.61 +/- 3.2 ng/mL (mean 1SD) were 5, 3 and 3%. Interassays CVs for the low, medium and high pool varied between 7-10, 5-7, and 6-9%. Reproducibility between 4 different lots showed a intraclass CV of 0.99 (95% CI 0.98-0.96). Logarithmically transformed IGF-I levels were linearly associated with age with a 13% reduction in IGF-I per decade in females and 11% in males. Conclusion: We have provided IGF-I reference ranges obtained by an assay that showed variations and reproducibility that was considered of sufficient high quality for clinical and scientific use.
引用
收藏
页码:880 / 885
页数:6
相关论文
共 19 条
[1]   Normal age-dependent values of serum insulin growth factor-I: Results from a healthy Italian population [J].
Aimaretti, G. ;
Boschetti, M. ;
Corneli, G. ;
Gasco, V. ;
Valle, D. ;
Borsotti, M. ;
Rossi, A. ;
Barreca, A. ;
Fazzuoli, L. ;
Ferone, D. ;
Ghigo, E. ;
Minuto, F. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (05) :445-449
[2]   Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system:: Results from a multicenter study [J].
Brabant, G ;
von zur Mühlen, A ;
Wüster, C ;
Ranke, MB ;
Kratzsch, J ;
Kiess, W ;
Ketelslegers, JM ;
Wilhelmsen, L ;
Hulthén, L ;
Saller, B ;
Mattsson, A ;
Wilde, J ;
Schemer, R ;
Kann, P .
HORMONE RESEARCH, 2003, 60 (02) :53-60
[3]   IGF-I assays: current assay methodologies and their limitations [J].
Clemmons, David R. .
PITUITARY, 2007, 10 (02) :121-128
[4]   Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) [J].
Elmlinger, MW ;
Kühnel, W ;
Weber, MM ;
Ranke, MB .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (06) :654-664
[5]   Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3) [J].
Harris, Tiffany G. ;
Strickler, Howard D. ;
Yu, Herbert ;
Pollak, Michael N. ;
Monrad, E. Scott ;
Travin, Mark I. ;
Xue, Xiaonan ;
Rohan, Thomas E. ;
Kaplan, Robert C. .
GROWTH HORMONE & IGF RESEARCH, 2006, 16 (02) :86-92
[6]   Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples [J].
Hartog, Hermien ;
van der Graaf, Winette T. A. ;
Wesseling, Jelle ;
van der Veer, Eveline ;
Boezen, H. Marike .
CLINICAL BIOCHEMISTRY, 2008, 41 (7-8) :636-639
[7]   A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide [J].
Holt, Richard I. G. ;
Erotokritou-Mulligan, Ioulietta ;
Ridley, Sean A. ;
McHugh, Cathy M. ;
Bassett, E. Eryl ;
Cowan, David A. ;
Bartlett, Christiaan ;
Soenksen, Peter H. .
GROWTH HORMONE & IGF RESEARCH, 2009, 19 (01) :43-50
[8]   Serum levels of insulin-like growth factor I and its binding proteins in health and disease [J].
Juul, A .
GROWTH HORMONE & IGF RESEARCH, 2003, 13 (04) :113-170
[9]   SERUM INSULIN-LIKE GROWTH FACTOR-I IN 1030 HEALTHY-CHILDREN, ADOLESCENTS, AND ADULTS - RELATION TO AGE, SEX, STAGE OF PUBERTY, TESTICULAR SIZE, AND BODY-MASS INDEX [J].
JUUL, A ;
BANG, P ;
HERTEL, NT ;
MAIN, K ;
DALGAARD, P ;
JORGENSEN, K ;
MULLER, J ;
HALL, K ;
SKAKKEBAEK, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03) :744-752
[10]   Centralized blood processing for the Selenium and Vitamin E cancer prevention trial: Effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability [J].
Kristal, AR ;
King, IB ;
Albanes, D ;
Pollak, MN ;
Stanzyk, FZ ;
Santella, RM ;
Hoque, A .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) :727-730